Pneumococcal type-associated variability in alternate complement pathway activation.
about
Pathogenesis and pathophysiology of bacterial meningitis.Role of complement in host defense against pneumococcal otitis mediaActivation of the alternative pathway of complement by mycobacteria and cord factor.Alterations in serum opsonic activity and complement levels in pneumococcal disease.Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide.Requirement for capsule in colonization by Streptococcus pneumoniae.Strain specificity of opsonins for group B streptococci types II and III.Alternate complement pathway activation by group A streptococci: role of M-protein.Complement activating factor(s) of Trypanosoma lewisi: some physiochemical characteristics of the active componentsComplement system in pneumococcal infections.Lung bacterial clearance in murine pneumococcal pneumoniaComplement levels in pneumococcal pneumonia.Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXVRole of antibody and complement in opsonization of group B streptococci.Evidence for quantitative variability of bacterial opsonic requirementsGenetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factorsA Three-Tiered Study of Differences in Murine Intrahost Immune Response to Multiple Pneumococcal Strains.Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assayImpaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathwayPneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigensDecreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection.Enzyme immunoassay for detection of pneumococcal antigen in cerebrospinal fluid.Interaction of pneumococcal antigens with complement in rats.Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Activation of the alternative complement pathway by Sporothrix schenckii.Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits.Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.Experimental type 25 pneumococcal pneumonia in rats: an electron-microscopic study.
P2860
Q30450181-CBBBA812-3E5B-4496-9B7F-56ADFF325462Q33399371-D5129324-1B33-4295-B24F-9690B38DEB63Q33904845-812FB91C-52FC-45D2-94CE-0C8268A4E5ABQ33907928-08943B7D-0A7C-45A7-B74F-3D4F0B57390AQ34001504-271306DC-F7C4-4828-8614-9F0064A00D32Q34007742-010176AA-B20C-4FA8-A045-6B97868F48BCQ34078837-5E372098-E686-4A81-B3C1-388445935FFBQ34101448-BF6736A2-9D49-4C0A-B22F-BD64E0540D58Q34119972-C30CCCB4-9F00-47B8-8354-9A30534EBE55Q34392698-711E6F8C-1928-4BF0-B2C5-0A9AED10B116Q34412153-5F42B165-55B0-4555-AE1F-ED68A5762D4FQ34415365-A31D01E9-5CF1-414A-91E4-1D09DC8C5A61Q34417746-FA790D35-AB47-41A3-B42C-E9794D093BC5Q34449325-642C9712-7018-42C5-9E79-F081BE3CC701Q34464286-FD32F522-8A00-40DD-8E58-164E0E0E80C2Q34521565-95549134-B62D-4575-9D65-A9DC9156A2F4Q35191928-F5561454-0177-4D31-BE9F-6B1A1A6B8DE5Q35317446-43FC8BB8-BC5C-41E9-921E-F22EC694DD94Q35779863-B4E5B983-32B0-4C45-84E7-70895300DED6Q35902720-CB39F846-21B5-4D34-B1E5-2984FC7C6CACQ35921138-B2874DE6-DC6B-41EA-9716-071A705FA717Q36437177-27502B68-D627-40A3-9587-3C7E4009227DQ36454624-0DF1B870-2AAF-49CE-9D08-10BE96FCDC72Q36804267-AF9FF6FB-E117-42ED-ADCB-ED81F6C3F2DBQ36963833-AFC9563A-8CB2-4C46-966D-940D4049CF0AQ36998931-94F265EF-DEFC-4E66-A4CE-ABACE7FC4B43Q37035971-D351CC84-563E-49DA-A24A-DF9F9034FFFFQ37200932-A275B6D9-78AA-4845-9BB2-670C7F28119CQ37271397-623556AD-EBE2-4AE1-BB02-C21085DB6436Q39257252-A1016E2E-1A67-4EF3-8D18-516B761B5F87Q39511742-1E71F2F9-8ED0-480C-A20D-C4F8CA110A7FQ40056277-CAF507FE-A516-4211-84EE-620DC66C27DFQ40165973-1CC02829-0A0C-490A-8397-BA38FEBFB3F6Q40184193-9EEF5724-7DDA-4002-B338-B8DF2E678A92Q40597978-36281DFB-488C-40F2-9C17-6B5C71E812DDQ40611116-016655DE-4114-4286-A0A3-20EE0C6B0783Q41181830-74CEDA51-688C-4387-A765-4805DF580740Q42735561-4B7F0BC6-253C-48F4-960C-DB8131551AEA
P2860
Pneumococcal type-associated variability in alternate complement pathway activation.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Pneumococcal type-associated variability in alternate complement pathway activation.
@en
Pneumococcal type-associated variability in alternate complement pathway activation.
@nl
type
label
Pneumococcal type-associated variability in alternate complement pathway activation.
@en
Pneumococcal type-associated variability in alternate complement pathway activation.
@nl
prefLabel
Pneumococcal type-associated variability in alternate complement pathway activation.
@en
Pneumococcal type-associated variability in alternate complement pathway activation.
@nl
P2860
P1476
Pneumococcal type-associated variability in alternate complement pathway activation.
@en
P2093
P2860
P304
P407
P577
1975-10-01T00:00:00Z